Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Seminars in Immunology|October 1, 1996
Tumors derived from antigen presenting cellsH I Levitsky
Neuroradiology|January 1, 1991
Early invasive CNS aspergillosis. An easily missed diagnosisA Shuper, H I Levitsky, D R Cornblath
Critical Reviews in Oncogenesis|January 1, 1996
Tolerance and cancer: a critical issue in tumor immunologyE M Sotomayor, I Borrello, H I Levitsky
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1991
The fate of CD4-8- T cell receptor-alpha beta+ thymocytesH I Levitsky, P T Golumbek, D M Pardoll
The Journal of Experimental Medicine|April 1, 1994
In vivo priming of two distinct antitumor effector populations: the role of MHC class I expressionH I Levitsky, A Lazenby, R J Hayashi, et al.
The Journal of Experimental Medicine|March 1, 1996
Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?A Y Huang, A T Bruce, D M Pardoll, et al.
Immunity|April 1, 1996
In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporterA Y Huang, A T Bruce, D M Pardoll, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 1999
In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific toleranceE M Sotomayor, I Borrello, E Tubb, et al.
Pageof 4